155 related articles for article (PubMed ID: 29668746)
1. Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder.
Wagner S; Helmreich I; Wollschläger D; Meyer K; Kaaden S; Reiff J; Roll SC; Braus D; Tüscher O; Müller-Dahlhaus F; Tadić A; Lieb K
PLoS One; 2018; 13(4):e0194574. PubMed ID: 29668746
[TBL] [Abstract][Full Text] [Related]
2. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
[No Abstract] [Full Text] [Related]
3. Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Bingham KS; Whyte EM; Meyers BS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ;
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1270-1275. PubMed ID: 26560512
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment.
Wagner S; Doering B; Helmreich I; Lieb K; Tadić A
Acta Psychiatr Scand; 2012 Apr; 125(4):281-92. PubMed ID: 22007857
[TBL] [Abstract][Full Text] [Related]
5. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
6. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
[TBL] [Abstract][Full Text] [Related]
8. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
9. A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.
Pimontel MA; Rindskopf D; Rutherford BR; Brown PJ; Roose SP; Sneed JR
Am J Geriatr Psychiatry; 2016 Jan; 24(1):31-41. PubMed ID: 26282222
[TBL] [Abstract][Full Text] [Related]
10. Effects of remission speed and improvement of cognitive functions of depressed patients.
Gudayol-Ferré E; Guàrdia-Olmos J; Peró-Cebollero M
Psychiatry Res; 2015 Mar; 226(1):103-12. PubMed ID: 25619432
[TBL] [Abstract][Full Text] [Related]
11. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
[TBL] [Abstract][Full Text] [Related]
12. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
[TBL] [Abstract][Full Text] [Related]
13. Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.
Engelmann J; Wagner S; Wollschläger D; Kaaden S; Schlicht KF; Dreimüller N; Braus DF; Müller MB; Tüscher O; Frieling H; Tadić A; Lieb K
Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):183-193. PubMed ID: 30929060
[TBL] [Abstract][Full Text] [Related]
14. Executive Function Predicts Antidepressant Treatment Noncompletion in Late-Life Depression.
Cristancho P; Lenze EJ; Dixon D; Miller JP; Mulsant BH; Reynolds CF; Butters MA
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29659205
[TBL] [Abstract][Full Text] [Related]
15. Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.
Alexopoulos GS; Manning K; Kanellopoulos D; McGovern A; Seirup JK; Banerjee S; Gunning F
Psychol Med; 2015 Oct; 45(14):3111-20. PubMed ID: 26169527
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
[TBL] [Abstract][Full Text] [Related]
17. Verbal memory predicts treatment outcome in syndromal anxious depression: An iSPOT-D report.
Braund TA; Tillman G; Palmer DM; Harris AWF
J Affect Disord; 2020 Jan; 260():245-253. PubMed ID: 31513968
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
19. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
Spronk D; Arns M; Barnett KJ; Cooper NJ; Gordon E
J Affect Disord; 2011 Jan; 128(1-2):41-8. PubMed ID: 20619899
[TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
